mRNA Platform Market to grow with a CAGR of 3.56% through 2030F
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global mRNA Platform Market.
According
to TechSci Research report, “mRNA Platform Market - Global Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2030F”, Global mRNA Platform Market
has valued at USD 7.30 billion in 2024 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 3.56% through 2030. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
The
speed of development is a significant driver of demand in the global mRNA
(messenger RNA) platform market. The mRNA platform's ability to accelerate the
development of vaccines, therapies, and other medical products has been a
game-changer in biotechnology and healthcare. One of the most prominent
examples of the speed of development in the mRNA platform market is the
development of COVID-19 vaccines. mRNA vaccine candidates for COVID-19 were
developed, tested, and authorized for emergency use in record time, often
within a matter of months. This speed was crucial in responding to a global
pandemic. The mRNA platform's flexibility allows for rapid adaptation to
emerging infectious pathogens and new variants. This is especially important in
addressing evolving public health threats. mRNA technology can be customized
quickly to target specific diseases or conditions. This customization enables
researchers and companies to respond rapidly to emerging healthcare challenges.
The speed of mRNA vaccine and therapy development has been facilitated by
expedited clinical trial processes during public health emergencies. Regulatory
agencies, such as the FDA, have worked closely with developers to streamline
the approval process.
Beyond
COVID-19, mRNA technology was being explored for a wide range of infectious
diseases, including influenza, HIV, and Zika virus. mRNA vaccines have the
advantage of rapid development and adaptation to new variants. Companies
working in the mRNA platform market were expanding their operations globally to
reach wider markets. This included collaborations with international partners
and establishing manufacturing facilities in different regions.
Storage and distribution present significant challenges in the global mRNA platform market, particularly for mRNA-based vaccines and therapies. These challenges are influenced by several factors related to the nature of mRNA molecules and the need to maintain their stability and integrity. mRNA molecules, especially those used in mRNA vaccines and therapies, are highly sensitive to temperature fluctuations. Maintaining the integrity of mRNA requires strict temperature control to prevent degradation. Some mRNA vaccines, such as the COVID-19 vaccines developed by Pfizer-BioNTech and Moderna, require storage at ultra-low temperatures (typically around -70°C or colder) to remain stable. This necessitates specialized storage and transportation infrastructure. Maintaining the cold chain, which is the temperature-controlled supply chain, for mRNA-based products is complex and costly. Ensuring that vaccines and therapies remain within the recommended temperature range from manufacturing to administration is challenging, especially in resource-limited regions.
Browse over XX market data Figures and spread through XX Pages and an
in-depth TOC on " mRNA Platform Market.”
Global mRNA Platform Market segmentation is based on Indication, Usability, mRNA Type, End User and Region.
Based on mRNA Type, The Global mRNA Platform Market is segmented into Nucleoside-Modified mRNA, Self-Amplifying mRNA, and Unmodified mRNA. Among these, Self-Amplifying mRNA is emerging as the fastest-growing segment due to its unique ability to replicate within cells, allowing for lower dosing while achieving strong and prolonged protein expression. This platform offers promising advantages for vaccine development, particularly in infectious disease and oncology applications, by enabling robust immune responses with enhanced efficacy. Additionally, advancements in delivery systems and increasing research investments are accelerating the adoption of self-amplifying mRNA technologies, driving rapid growth in this segment.
Based on Region, Asia-pacific region to fastest growth in
the Global mRNA Platform Market. The Asia-Pacific region is home to a large and
diverse population, including some of the world's most populous countries such
as China and India. This demographic diversity presents a substantial market
for vaccines, therapies, and other mRNA-based medical products. Many countries
in the Asia-Pacific region were increasing their investments in healthcare
infrastructure and research and development. This investment created an environment
conducive to the development and adoption of innovative medical technologies
like mRNA therapies and vaccines. The region's history of emerging infectious
diseases, such as SARS and MERS, highlighted the need for advanced vaccine
technologies. mRNA vaccines, known for their rapid development capabilities,
were seen as valuable tools for responding to future outbreaks.
Some
of the major companies operating in the Global
mRNA Platform Market include:
- AstraZeneca
PLC
- Asuragen,
Inc.
- Catalent
Pharma Solutions
- Arcturus
Therapeutics, Inc.
- BioNTech
AG
- CRISPR
Therapeutics Inc.
- AKESOgen,
Inc.
- baseclick
GmbH
- Accent
Therapeutics Inc.
- Accanis
Biotech F&E GmbH & Co KG
Download Free Sample Report
Customers can also request
10% free customization on this report.
“Certain areas, particularly in
North America, are projected to exert significant demand for mRNA Platform. The
growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the Global mRNA
Platform Market in the forecast period," said Mr. Karan Chechi, Research
Director pf TechSci Research, a research-based Global management consulting
firm.
"mRNA Platform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Autoimmune Diseases, Cancer, Infectious Diseases, Rare Diseases, Respiratory Diseases), By Usability (Prophylactic Vaccines, Therapeutic Drugs, Therapeutic Vaccines), By mRNA Type (Nucleoside-Modified mRNA, Self-Amplifying mRNA, Unmodified mRNA), By End User (Hospitals & Clinics, Pharmaceutical Companies, Research Organization), By Region & Competition, 2020-2030F", evaluated the future
growth potential of Global mRNA Platform Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global mRNA Platform Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com